세계의 바이오포토닉스 시장 : 규모, 점유율, 동향 분석(기술별, 최종 용도별, 용도별, 지역별), 전망, 예측(2025-2032년)

The Global BioPhotonics Market size is expected to reach $156.85 billion by 2032, rising at a market growth of 10% CAGR during the forecast period.

The demand for in-vitro BioPhotonic tools is expanding rapidly due to increasing focus on precision diagnostics, especially in oncology, infectious disease screening, and autoimmune disorder monitoring. The rise of genomics and personalized medicine has further reinforced the importance of light-based platforms that offer fast, accurate, and minimally disruptive analysis. A notable trend in the in-vitro segment is the increasing adoption of automated, high-throughput optical systems.

The increasing demand for non-invasive and minimally invasive diagnostics is a significant driver propelling the growth of the BioPhotonics market. BioPhotonics, which combines the principles of photonics and biology, offers advanced diagnostic tools that enable the visualization and analysis of biological tissues without the need for invasive procedures. Thus, increasing demand for non-invasive and minimally invasive diagnostics is driving the growth of the market.

Additionally, The integration of nanotechnology with BioPhotonics is significantly advancing the capabilities of biomedical diagnostics and therapeutics. By combining the manipulation of light with nanoscale materials, this interdisciplinary approach enhances the sensitivity, specificity, and functionality of diagnostic tools, enabling real-time, non-invasive analysis of biological systems. In conclusion, the integration of nanotechnology with BioPhotonics is revolutionizing the biomedical field by providing powerful tools for diagnosis, therapy, and tissue engineering.

However, The high cost associated with BioPhotonics devices and systems stands as a significant barrier to the widespread adoption of these technologies. Advanced BioPhotonics equipment, such as optical coherence tomography (OCT) systems, fluorescence imaging devices, and Raman spectroscopy instruments, involve complex manufacturing processes and incorporate sophisticated components like lasers, detectors, and high-precision optics. Hence, high cost of BioPhotonics devices and systems are hindering the growth of the market.

Technology Outlook

Based on Technology, the market is segmented into In-Vitro, and In-Vivo. In-vivo BioPhotonics refers to the use of optical technologies to study biological processes within living organisms in a non-invasive or minimally invasive manner. This segment is fundamental in modern diagnostics and therapy monitoring, providing real-time visualization of tissues, organs, and cellular functions. Common applications include optical coherence tomography (OCT), fluorescence-guided surgery, photoacoustic imaging, and near-infrared spectroscopy (NIRS), all of which are instrumental in early disease detection and surgical decision-making.

End Use Outlook

Based on End Use, the market is segmented into Medical Diagnostics, Tests & Components, Medical Therapeutics, and Non-medical Application. Medical therapeutics in BioPhotonics involves the use of light to treat medical conditions, encompassing applications such as photodynamic therapy (PDT), light-based surgery, and laser-assisted drug delivery. These technologies utilize specific wavelengths of light to activate therapeutic agents, ablate tissues, or modulate cellular activity with high precision. BioPhotonics-based therapeutics are increasingly used in oncology, ophthalmology, dermatology, and pain management, offering advantages like minimal invasiveness, targeted action, and faster recovery times.

Application Outlook

Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging, and Biosensors & Others. Microscopy applications in BioPhotonics are central to biomedical research, cellular imaging, and drug development. Advanced techniques such as multiphoton microscopy, confocal microscopy, and fluorescence lifetime imaging allow for detailed visualization of cellular structures, protein interactions, and tissue morphology. A key trend is the evolution of super-resolution microscopy and real-time live-cell imaging, enabling researchers to explore subcellular phenomena with nanometer precision.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North American BioPhotonics market is poised for continued growth, driven by technological advancements, supportive regulatory frameworks, and increasing healthcare demands. Ongoing research and development efforts, coupled with strategic industry collaborations, are expected to further expand the applications and accessibility of BioPhotonic technologies across the region.

List of Key Companies Profiled

• Oxford Instruments plc
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• IPG Photonics Corporation
• Lumenis Be Ltd.
• Becton, Dickinson and Company
• Shimadzu Corporation
• Carl Zeiss AG
• Olympus Corporation
• Hamamatsu Photonics K.K.

Global BioPhotonics Market Report Segmentation

By Technology

• In-Vitro
• In-Vivo

By End Use

• Medical Diagnostics
• Tests & Components
• Medical Therapeutics
• Non-medical Application

By Application

• See-Through imaging
• Microscopy
• Inside Imaging
• Spectro Molecular
• Analytics Sensing
• Light Therapy
• Surface Imaging
• Biosensors & Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global BioPhotonics Market, by Technology
  • 1.4.2 Global BioPhotonics Market, by End Use
  • 1.4.3 Global BioPhotonics Market, by Application
  • 1.4.4 Global BioPhotonics Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
  • 3.2.3 Market Opportunities
  • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

• 4.1 Market Share Analysis, 2024
• 4.2 Porter Five Forces Analysis

Chapter 5. Key Customer Criteria in the BioPhotonics Market

• 5.1 Accuracy and Sensitivity
• 5.2 Non-Invasiveness and Patient Safety
• 5.3 Portability and Ease of Integration
• 5.4 Speed and Real-Time Capabilities
• 5.5 Regulatory Approvals and Compliance
• 5.6 Cost-Effectiveness and ROI
• 5.7 Customizability and Application Flexibility
• 5.8 Technical Support and Training
• 5.9 Data Handling and Software Integration
• 5.10. Brand Reputation and Clinical Validation

Chapter 6. Global BioPhotonics Market by Technology

• 6.1 Global In-Vitro Market by Region
• 6.2 Global In-Vivo Market by Region

Chapter 7. Global BioPhotonics Market by End Use

• 7.1 Global Medical Diagnostics Market by Region
• 7.2 Global Tests & Components Market by Region
• 7.3 Global Medical Therapeutics Market by Region
• 7.4 Global Non-medical Application Market by Region

Chapter 8. Global BioPhotonics Market by Application

• 8.1 Global See-Through imaging Market by Region
• 8.2 Global Microscopy Market by Region
• 8.3 Global Inside Imaging Market by Region
• 8.4 Global Spectro Molecular Market by Region
• 8.5 Global Analytics Sensing Market by Region
• 8.6 Global Light Therapy Market by Region
• 8.7 Global Surface Imaging Market by Region
• 8.8 Global Biosensors & Others Market by Region

Chapter 9. Global BioPhotonics Market by Region

• 9.1 North America BioPhotonics Market
  • 9.1.1 North America BioPhotonics Market by Technology
    • 9.1.1.1 North America In-Vitro Market by Country
    • 9.1.1.2 North America In-Vivo Market by Country
  • 9.1.2 North America BioPhotonics Market by End Use
    • 9.1.2.1 North America Medical Diagnostics Market by Country
    • 9.1.2.2 North America Tests & Components Market by Country
    • 9.1.2.3 North America Medical Therapeutics Market by Country
    • 9.1.2.4 North America Non-medical Application Market by Country
  • 9.1.3 North America BioPhotonics Market by Application
    • 9.1.3.1 North America See-Through imaging Market by Country
    • 9.1.3.2 North America Microscopy Market by Country
    • 9.1.3.3 North America Inside Imaging Market by Country
    • 9.1.3.4 North America Spectro Molecular Market by Country
    • 9.1.3.5 North America Analytics Sensing Market by Country
    • 9.1.3.6 North America Light Therapy Market by Country
    • 9.1.3.7 North America Surface Imaging Market by Country
    • 9.1.3.8 North America Biosensors & Others Market by Country
  • 9.1.4 North America BioPhotonics Market by Country
    • 9.1.4.1 US BioPhotonics Market
      • 9.1.4.1.1 US BioPhotonics Market by Technology
      • 9.1.4.1.2 US BioPhotonics Market by End Use
      • 9.1.4.1.3 US BioPhotonics Market by Application
    • 9.1.4.2 Canada BioPhotonics Market
      • 9.1.4.2.1 Canada BioPhotonics Market by Technology
      • 9.1.4.2.2 Canada BioPhotonics Market by End Use
      • 9.1.4.2.3 Canada BioPhotonics Market by Application
    • 9.1.4.3 Mexico BioPhotonics Market
      • 9.1.4.3.1 Mexico BioPhotonics Market by Technology
      • 9.1.4.3.2 Mexico BioPhotonics Market by End Use
      • 9.1.4.3.3 Mexico BioPhotonics Market by Application
    • 9.1.4.4 Rest of North America BioPhotonics Market
      • 9.1.4.4.1 Rest of North America BioPhotonics Market by Technology
      • 9.1.4.4.2 Rest of North America BioPhotonics Market by End Use
      • 9.1.4.4.3 Rest of North America BioPhotonics Market by Application
• 9.2 Europe BioPhotonics Market
  • 9.2.1 Europe BioPhotonics Market by Technology
    • 9.2.1.1 Europe In-Vitro Market by Country
    • 9.2.1.2 Europe In-Vivo Market by Country
  • 9.2.2 Europe BioPhotonics Market by End Use
    • 9.2.2.1 Europe Medical Diagnostics Market by Country
    • 9.2.2.2 Europe Tests & Components Market by Country
    • 9.2.2.3 Europe Medical Therapeutics Market by Country
    • 9.2.2.4 Europe Non-medical Application Market by Country
  • 9.2.3 Europe BioPhotonics Market by Application
    • 9.2.3.1 Europe See-Through imaging Market by Country
    • 9.2.3.2 Europe Microscopy Market by Country
    • 9.2.3.3 Europe Inside Imaging Market by Country
    • 9.2.3.4 Europe Spectro Molecular Market by Country
    • 9.2.3.5 Europe Analytics Sensing Market by Country
    • 9.2.3.6 Europe Light Therapy Market by Country
    • 9.2.3.7 Europe Surface Imaging Market by Country
    • 9.2.3.8 Europe Biosensors & Others Market by Country
  • 9.2.4 Europe BioPhotonics Market by Country
    • 9.2.4.1 Germany BioPhotonics Market
      • 9.2.4.1.1 Germany BioPhotonics Market by Technology
      • 9.2.4.1.2 Germany BioPhotonics Market by End Use
      • 9.2.4.1.3 Germany BioPhotonics Market by Application
    • 9.2.4.2 UK BioPhotonics Market
      • 9.2.4.2.1 UK BioPhotonics Market by Technology
      • 9.2.4.2.2 UK BioPhotonics Market by End Use
      • 9.2.4.2.3 UK BioPhotonics Market by Application
    • 9.2.4.3 France BioPhotonics Market
      • 9.2.4.3.1 France BioPhotonics Market by Technology
      • 9.2.4.3.2 France BioPhotonics Market by End Use
      • 9.2.4.3.3 France BioPhotonics Market by Application
    • 9.2.4.4 Russia BioPhotonics Market
      • 9.2.4.4.1 Russia BioPhotonics Market by Technology
      • 9.2.4.4.2 Russia BioPhotonics Market by End Use
      • 9.2.4.4.3 Russia BioPhotonics Market by Application
    • 9.2.4.5 Spain BioPhotonics Market
      • 9.2.4.5.1 Spain BioPhotonics Market by Technology
      • 9.2.4.5.2 Spain BioPhotonics Market by End Use
      • 9.2.4.5.3 Spain BioPhotonics Market by Application
    • 9.2.4.6 Italy BioPhotonics Market
      • 9.2.4.6.1 Italy BioPhotonics Market by Technology
      • 9.2.4.6.2 Italy BioPhotonics Market by End Use
      • 9.2.4.6.3 Italy BioPhotonics Market by Application
    • 9.2.4.7 Rest of Europe BioPhotonics Market
      • 9.2.4.7.1 Rest of Europe BioPhotonics Market by Technology
      • 9.2.4.7.2 Rest of Europe BioPhotonics Market by End Use
      • 9.2.4.7.3 Rest of Europe BioPhotonics Market by Application
• 9.3 Asia Pacific BioPhotonics Market
  • 9.3.1 Asia Pacific BioPhotonics Market by Technology
    • 9.3.1.1 Asia Pacific In-Vitro Market by Country
    • 9.3.1.2 Asia Pacific In-Vivo Market by Country
  • 9.3.2 Asia Pacific BioPhotonics Market by End Use
    • 9.3.2.1 Asia Pacific Medical Diagnostics Market by Country
    • 9.3.2.2 Asia Pacific Tests & Components Market by Country
    • 9.3.2.3 Asia Pacific Medical Therapeutics Market by Country
    • 9.3.2.4 Asia Pacific Non-medical Application Market by Country
  • 9.3.3 Asia Pacific BioPhotonics Market by Application
    • 9.3.3.1 Asia Pacific See-Through imaging Market by Country
    • 9.3.3.2 Asia Pacific Microscopy Market by Country
    • 9.3.3.3 Asia Pacific Inside Imaging Market by Country
    • 9.3.3.4 Asia Pacific Spectro Molecular Market by Country
    • 9.3.3.5 Asia Pacific Analytics Sensing Market by Country
    • 9.3.3.6 Asia Pacific Light Therapy Market by Country
    • 9.3.3.7 Asia Pacific Surface Imaging Market by Country
    • 9.3.3.8 Asia Pacific Biosensors & Others Market by Country
  • 9.3.4 Asia Pacific BioPhotonics Market by Country
    • 9.3.4.1 China BioPhotonics Market
      • 9.3.4.1.1 China BioPhotonics Market by Technology
      • 9.3.4.1.2 China BioPhotonics Market by End Use
      • 9.3.4.1.3 China BioPhotonics Market by Application
    • 9.3.4.2 Japan BioPhotonics Market
      • 9.3.4.2.1 Japan BioPhotonics Market by Technology
      • 9.3.4.2.2 Japan BioPhotonics Market by End Use
      • 9.3.4.2.3 Japan BioPhotonics Market by Application
    • 9.3.4.3 India BioPhotonics Market
      • 9.3.4.3.1 India BioPhotonics Market by Technology
      • 9.3.4.3.2 India BioPhotonics Market by End Use
      • 9.3.4.3.3 India BioPhotonics Market by Application
    • 9.3.4.4 South Korea BioPhotonics Market
      • 9.3.4.4.1 South Korea BioPhotonics Market by Technology
      • 9.3.4.4.2 South Korea BioPhotonics Market by End Use
      • 9.3.4.4.3 South Korea BioPhotonics Market by Application
    • 9.3.4.5 Singapore BioPhotonics Market
      • 9.3.4.5.1 Singapore BioPhotonics Market by Technology
      • 9.3.4.5.2 Singapore BioPhotonics Market by End Use
      • 9.3.4.5.3 Singapore BioPhotonics Market by Application
    • 9.3.4.6 Malaysia BioPhotonics Market
      • 9.3.4.6.1 Malaysia BioPhotonics Market by Technology
      • 9.3.4.6.2 Malaysia BioPhotonics Market by End Use
      • 9.3.4.6.3 Malaysia BioPhotonics Market by Application
    • 9.3.4.7 Rest of Asia Pacific BioPhotonics Market
      • 9.3.4.7.1 Rest of Asia Pacific BioPhotonics Market by Technology
      • 9.3.4.7.2 Rest of Asia Pacific BioPhotonics Market by End Use
      • 9.3.4.7.3 Rest of Asia Pacific BioPhotonics Market by Application
• 9.4 LAMEA BioPhotonics Market
  • 9.4.1 LAMEA BioPhotonics Market by Technology
    • 9.4.1.1 LAMEA In-Vitro Market by Country
    • 9.4.1.2 LAMEA In-Vivo Market by Country
  • 9.4.2 LAMEA BioPhotonics Market by End Use
    • 9.4.2.1 LAMEA Medical Diagnostics Market by Country
    • 9.4.2.2 LAMEA Tests & Components Market by Country
    • 9.4.2.3 LAMEA Medical Therapeutics Market by Country
    • 9.4.2.4 LAMEA Non-medical Application Market by Country
  • 9.4.3 LAMEA BioPhotonics Market by Application
    • 9.4.3.1 LAMEA See-Through imaging Market by Country
    • 9.4.3.2 LAMEA Microscopy Market by Country
    • 9.4.3.3 LAMEA Inside Imaging Market by Country
    • 9.4.3.4 LAMEA Spectro Molecular Market by Country
    • 9.4.3.5 LAMEA Analytics Sensing Market by Country
    • 9.4.3.6 LAMEA Light Therapy Market by Country
    • 9.4.3.7 LAMEA Surface Imaging Market by Country
    • 9.4.3.8 LAMEA Biosensors & Others Market by Country
  • 9.4.4 LAMEA BioPhotonics Market by Country
    • 9.4.4.1 Brazil BioPhotonics Market
      • 9.4.4.1.1 Brazil BioPhotonics Market by Technology
      • 9.4.4.1.2 Brazil BioPhotonics Market by End Use
      • 9.4.4.1.3 Brazil BioPhotonics Market by Application
    • 9.4.4.2 Argentina BioPhotonics Market
      • 9.4.4.2.1 Argentina BioPhotonics Market by Technology
      • 9.4.4.2.2 Argentina BioPhotonics Market by End Use
      • 9.4.4.2.3 Argentina BioPhotonics Market by Application
    • 9.4.4.3 UAE BioPhotonics Market
      • 9.4.4.3.1 UAE BioPhotonics Market by Technology
      • 9.4.4.3.2 UAE BioPhotonics Market by End Use
      • 9.4.4.3.3 UAE BioPhotonics Market by Application
    • 9.4.4.4 Saudi Arabia BioPhotonics Market
      • 9.4.4.4.1 Saudi Arabia BioPhotonics Market by Technology
      • 9.4.4.4.2 Saudi Arabia BioPhotonics Market by End Use
      • 9.4.4.4.3 Saudi Arabia BioPhotonics Market by Application
    • 9.4.4.5 South Africa BioPhotonics Market
      • 9.4.4.5.1 South Africa BioPhotonics Market by Technology
      • 9.4.4.5.2 South Africa BioPhotonics Market by End Use
      • 9.4.4.5.3 South Africa BioPhotonics Market by Application
    • 9.4.4.6 Nigeria BioPhotonics Market
      • 9.4.4.6.1 Nigeria BioPhotonics Market by Technology
      • 9.4.4.6.2 Nigeria BioPhotonics Market by End Use
      • 9.4.4.6.3 Nigeria BioPhotonics Market by Application
    • 9.4.4.7 Rest of LAMEA BioPhotonics Market
      • 9.4.4.7.1 Rest of LAMEA BioPhotonics Market by Technology
      • 9.4.4.7.2 Rest of LAMEA BioPhotonics Market by End Use
      • 9.4.4.7.3 Rest of LAMEA BioPhotonics Market by Application

Chapter 10. Company Profiles

• 10.1 Oxford Instruments plc
  • 10.1.1 Company Overview
  • 10.1.2 Financial Analysis
  • 10.1.3 Segmental and Regional Analysis
  • 10.1.4 Research & Development Expenses
• 10.2 Thermo Fisher Scientific, Inc.
  • 10.2.1 Company Overview
  • 10.2.2 Financial Analysis
  • 10.2.3 Segmental and Regional Analysis
  • 10.2.4 Research & Development Expenses
  • 10.2.5 SWOT Analysis
• 10.3 Bio-Rad laboratories, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Financial Analysis
  • 10.3.3 Segmental and Regional Analysis
  • 10.3.4 Research & Development Expenses
  • 10.3.5 SWOT Analysis
• 10.4 IPG Photonics Corporation
  • 10.4.1 Company Overview
  • 10.4.2 Financial Analysis
  • 10.4.3 Segmental and Regional Analysis
  • 10.4.4 Research & Development Expenses
• 10.5 Lumenis Be Ltd.
  • 10.5.1 Company Overview
  • 10.5.2 SWOT Analysis
• 10.6 Becton, Dickinson, and Company
  • 10.6.1 Company Overview
  • 10.6.2 Financial Analysis
  • 10.6.3 Segmental and Regional Analysis
  • 10.6.4 Research & Development Expense
  • 10.6.5 SWOT Analysis
• 10.7 Shimadzu Corporation
  • 10.7.1 Company Overview
  • 10.7.2 Financial Analysis
  • 10.7.3 Segmental and Regional Analysis
  • 10.7.4 Research & Development Expenses
  • 10.7.5 SWOT Analysis
• 10.8 Carl Zeiss AG
  • 10.8.1 Company Overview
  • 10.8.2 Financial Analysis
  • 10.8.3 Segmental and Regional Analysis
  • 10.8.4 Research & Development Expenses
  • 10.8.5 SWOT Analysis
• 10.9 Olympus Corporation
  • 10.9.1 Company Overview
  • 10.9.2 Financial Analysis
  • 10.9.3 Segmental and Regional Analysis
  • 10.9.4 SWOT Analysis
• 10.10. Hamamatsu Photonics K.K.
  • 10.10.1 Company Overview
  • 10.10.2 Financial Analysis
  • 10.10.3 Segmental Analysis
  • 10.10.4 Research & Development Expense
  • 10.10.5 SWOT Analysis

Chapter 11. Winning Imperatives of BioPhotonics Market